SCHEMBL2880155

SCHEMBL2880155

CC(=O)Nc1cccc(-c2ccc(-c3cc4ccnn4c(Nc4ccc(N)cc4)n3)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.43
CYP17A1 P05093 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
BACE1 P56817 1/20 0.42
RAD52 P43351 1/20 0.42
PKM P14618 1/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
KMT2A Q03164 2/20 0.42
RXFP1 Q9HBX9 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP2C19 P33261 1/20 0.42
SYK P43405 1/20 0.41
BRAF P15056 2/20 0.41
ABCB1 P08183 1/20 0.41
ABCC1 P33527 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881428 0.91 FYN (0.51) PLK1CYP17A1CYP11B1CYP11B2BACE1
SCHEMBL2216413 0.86 CYP17A1 (0.49) PLK1CYP17A1CYP11B1CYP11B2RAD52
SCHEMBL2215002 0.85 JAK2 (0.45) CYP17A1CYP11B1CYP11B2RAD52PKM
SCHEMBL2214475 0.85 JAK2 (0.43) CYP17A1CYP11B1CYP11B2RAD52PKM
SCHEMBL2214780 0.83 PLAU (0.41) BRAFABCB1ABCG2FYN
SCHEMBL2876734 0.82 BCDIN3D (0.42) BACE1MEN1MAPTKMT2ACYP2C19
SCHEMBL2215099 0.81 POLB (0.47) PLK1CYP17A1CYP11B1CYP11B2RAD52
SCHEMBL2216196 0.80 PRMT1 (0.45) PKMMEN1MAPTKMT2ANPSR1
SCHEMBL2881795 0.80 PLK1 (0.44) PLK1MEN1ALDH1A1MAPTKMT2A
SCHEMBL2882015 0.79 CYP17A1 (0.47) CYP17A1CYP11B1CYP11B2BACE1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745446-B2 Pyrazolo[1,5-c]pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-29 US disclosed
US-20070254046-A1 Novel Pyrazolopyrimidines ALTANA PHARMA AG (DE) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254046-A1 Novel Pyrazolopyrimidines MCL1, RARS2, CDK4 PLK1 695/4885CYP17A1 3208/4885CYP11B1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.